Intravenous Administration of Human Umbilical Cord Mesenchymal Stromal Cells Leads to an Inflammatory Response in the Lung
Mesenchymal stromal cells (MSCs) administered intravenously (IV) have shown efficacy in preclinical models of various diseases. This is despite the cells not reaching the site of injury due to entrapment in the lungs. The immunomodulatory properties of MSCs are thought to underlie their therapeutic...
Saved in:
| Main Authors: | Alejandra Hernandez Pichardo, Bettina Wilm, Neill J. Liptrott, Patricia Murray |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2023/7397819 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recommendations for the safe implementation of intravenous administration of mesenchymal stromal cells
by: Shuji Terai, et al.
Published: (2025-06-01) -
Therapeutic and continuative effects of human umbilical cord–derived mesenchymal stromal cells in food-allergic mice
by: Yuan Zhao, et al.
Published: (2025-03-01) -
Therapeutic Potential of Umbilical Cord Mesenchymal Stromal Cells Transplantation for Cerebral Palsy: A Case Report
by: Liming Wang, et al.
Published: (2013-01-01) -
Safety and efficacy of human umbilical cord-derived mesenchymal stromal cells in fetal ovine myelomeningocele repair
by: Yoann Athiel, et al.
Published: (2024-11-01) -
Wharton’s jelly mesenchymal stromal cells derived from preterm umbilical cord reveal a hepatogenic potential
by: F. Timoneri, et al.
Published: (2025-06-01)